Physicians' Academy for Cardiovascular Education

Agenda Topics ▼Video ▼Online-CME News ▼Meeting Reports Slides ▼About

ACC.19 ▼AHA 2018 ▼Diabetes & CVD ▼EAS 2019 ▼Epigenetics in CVD ▼ESC 2018 ▼Expert Meeting GLP-1, CVD & T2DM ▼HFpEF: The essentials to know ▼Invest in your arteries ▼LDL-c Expert Meeting ▼LDL-c Key Lessons ▼PCSK9 ▼

HoFH

Feb. 8, 2014

Share this page with your colleagues and friends:

Continue reading:

5 Things a cardiologist should know about diabetes

Slide Curriculum: Diabetes and cardiology

Slides (curriculum) - July 24, 2018

PACE Special: 5 Things a cardiologist should know about diabetes

Download - Download your free copy

Hypoglycemia in cardiovascular medicine: why worry?

10' education - Mar. 7, 2018 - Prof Guntram Schernthaner - Vienna, Austria - Online CME

ACS

No mortality benefit of beta-blocker in stable CAD beyond one year after MI, according to registry data

Literature - June 24, 2019 - Sorbets E et al., - Eur Heart J. 2019

Benefits of dual COMPASS regimen also seen in patients with moderate renal dysfunction

Literature - May 21, 2019 - Fox KAA et al., - J Am Coll Cardiol. 2019

FDA expands indication for PCSK9 inhibitor to prevent major CV events in adults with CVD

News - May 6, 2019

Atherosclerosis

High CAC score associated with increased mortality in young adults

Literature - Aug. 8, 2019 - Miedema MD et al. - JAMA Netw Open 2019

2019 Anitschkow Award given for defining genetic determinants of plasma lipid levels and CV risk

News - May 27, 2019

Majority of statin-eligible US adults not taking a statin were never offered the therapy

Literature - Apr. 11, 2019 - Bradley CK et al. - J Am Heart Assoc. 2019

Atrial fibrillation

Artificial intelligence helps pick up AF in ECG acquired during normal sinus rhythm

Literature - Aug. 14, 2019 - Attia Z et al., - The Lancet 2019

Factor Xa inhibitor effective and safe in AF patients with liver disease

Literature - July 23, 2019 - Qamar A, et al. - J Am Coll Cardiol 2019

No reduction in mortality and CV outcomes with catheter ablation in AF

Literature - Apr. 2, 2019 - Packer DL, et al. - JAMA 2019

CV Inflammation

Understanding and managing obesity-related HFpEF

10' education - July 22, 2019 - Milton Packer, MD

High residual inflammatory risk associated with adverse clinical outcomes in patients undergoing PCI with low LDL-c

Literature - June 7, 2019 - Guedeney P et al. - JACC 2019

Effect of IL-1β inhibition on lung cancer sheds new light on the role of inflammation

3' education - May 28, 2019 - EAS 2019, Maastricht - Paul Ridker, MD

CVRM

Assessing individual CV risk and treatment effect with U-Prevent

10' education - July 2, 2019 - Jannick Dorresteijn, MD, PhD

Quitting smoking after first CV event strongly lowers risk of recurrent event and mortality

Literature - July 1, 2019 - Van den Berg MJ et al., - Am J Heart 2019

ESC Preventive Cardiology section expresses preference for CV risk prediction tool

News - June 26, 2019

Diabetes

Clinical outcomes of GLP-1 RA in kidney disease: Current evidence and ongoing trials

10' education - July 12, 2019 - ERA-EDTA 2019 - Frederik Persson, MD

Importance of protection and prevention in diabetic cardiorenal disease

10' education - July 12, 2019 - ERA-EDTA 2019 - Prof. John Deanfield, MD

Sustained moderate calorie restriction yields cardiometabolic benefits in healthy adults

Literature - Aug. 7, 2019 - Kraus WE et al. - Lancet Diabetes Endocrinol 2019

Familial Hypercholesterolemia

ANGPTL3 antibody halves LDL-c levels in HoFH patients in phase 3 trial

News - Aug. 15, 2019

Prevalence and relevance of elevated Lp(a) in familial hypercholesterolemia

5' education - May 24, 2019 - EAS endorsed Lp(a) satellite meeting - Prof. Børge Nordestgaard, MD

Blood donor screening as potential strategy for FH screening

Literature - June 25, 2019 - Jackson CL et al. - JAMA Cardiol 2019

GLP-1 RA & CVD

Clinical outcomes of GLP-1 RA in kidney disease: Current evidence and ongoing trials

10' education - July 12, 2019 - ERA-EDTA 2019 - Frederik Persson, MD

Importance of protection and prevention in diabetic cardiorenal disease

10' education - July 12, 2019 - ERA-EDTA 2019 - Prof. John Deanfield, MD

Impact of novel guidelines: Transforming diabetes management in cardiology

Agenda - Sep. 3, 2019 - ESC Paris, France

Heart Failure

Digoxin discontinuation associated with worse outcomes in HFrEF

Lower neprilysin levels in HFpEF

Literature - Aug. 13, 2019 - Lyle MA et al. - JACC Heart Fail 2019

Summary | Real world evidence and outcomes in the management of heart failure patients with T2DM

Athens, Greece – May 25, 2019

HFpEF: The essentials to know

HFpEF: Current and future clinical approaches to manage HFpEF

10' education - Aug. 27, 2018 - Burkert Pieske, MD - Berlin, Germany - Online CME

Slides: HFpEF: What are the most likely pathophysiological mechanisms involved in the disease

Slides (presentation) - Aug. 27, 2018 - Carolyn Lam, MD - Singapore

HFpEF: How to diagnose

10' education - Aug. 27, 2018 - Barry Borlaug - Rochester, MN, USA - Online CME

Hypertension

Systolic and diastolic hypertension independently associated with CV outcomes

Literature - July 22, 2019 - Flint AC et al. - N Engl J Med 2019

RAAS inhibition in patients with kidney disease: Balancing the benefits and risks

10' education - July 12, 2019 - ERA-EDTA 2019 - Prof. Patrick Rossignol, MD

Use of patiromer results in more patients remaining on spironolactone in resistant hypertension and CKD, with and without HF

News - May 25, 2019

Inflammation Expert Opinions

Ultime notizie sulla terapia: Un farmaco anti-infiammatorio riduce eventi cardiovascolari maggiori

5' education - Aug. 27, 2017 - ESC 2017, Barcelona, Spain

Breakthrough therapy: Anti-inflammatory drug can affect important CV outcomes

5' education - Aug. 27, 2017 - ESC 2017, Barcelona, Spain

Clinical implications of inhibiting inflammation as risk factor for progression of CVD

5' education - Aug. 27, 2017

Invest in your arteries

Estimating CV risk and treatment benefit

10' education - June 12, 2018 - Prof. Frank Visseren - Utrecht, The Netherlands - Online CME

Importance of hypertension in CVD prevention

10' education - June 12, 2018 - Prof. Richard Hobbs - Oxford, UK - Online CME

The role of lipids in CVD prevention: Lessons learned about statins

10' education - June 6, 2018 - Prof. Kees Hovingh - Amsterdam, The Netherlands - Online CME

Lipids

ANGPTL3 antibody halves LDL-c levels in HoFH patients in phase 3 trial

News - Aug. 15, 2019

Lp(a) apheresis and CVD risk modulation

5' education - May 24, 2019 - EAS-endorsed Lp(a) satellite meeting - Elisa Waldmann, MD

Prevalence and relevance of elevated Lp(a) in familial hypercholesterolemia

5' education - May 24, 2019 - EAS endorsed Lp(a) satellite meeting - Prof. Børge Nordestgaard, MD

Lp(a)

Entry of Lp(a) into the CV arena

5' education - May 24, 2019 - EAS-endorsed Lp(a) satellite meeting - Prof. Florian Kronenberg, MD

Lp(a) apheresis and CVD risk modulation

5' education - May 24, 2019 - EAS-endorsed Lp(a) satellite meeting - Elisa Waldmann, MD

Prevalence and relevance of elevated Lp(a) in familial hypercholesterolemia

5' education - May 24, 2019 - EAS endorsed Lp(a) satellite meeting - Prof. Børge Nordestgaard, MD

PCSK9

LDL-c Guidance on the novel ESC/EAS dyslipidaemia guidelines: Expert discussions on practical implications

Agenda - Sep. 3, 2019 - ESC Paris, France

PCSK9i, changing practice in cardiology: The emerging story

Agenda - Aug. 31, 2019 - ESC Paris, France

LDL-c lowering PCSK9 gene variants associated with lower CV mortality in general population

Literature - July 1, 2019 - Benn M et al. - J Am Coll Cardiol. 2019

Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension: Key questions addressed

Online-CME - This course consists of 3 separate lectures

Why cardiologists should be more interested in PAH

3' education - Mar. 9, 2018 - VBWG at ACC, Orlando, FL, USA - Prof. Mardi Gomberg-Maitland, Falls Church, VA, USA - Online CME

Novel insights in the management and prognosis of pulmonary hypertension

5' education - Aug. 29, 2017 - ESC 2017, Barcelona, Spain - Prof Nazzareno Galiè - Bologna, Italy

Stroke

Systolic and diastolic hypertension independently associated with CV outcomes

Literature - July 22, 2019 - Flint AC et al. - N Engl J Med 2019

Vitamin D supplementation not associated with reduced major adverse CV events

Literature - July 1, 2019 - Barbarawi M, et al. - JAMA Cardiol 2019

Higher BMI associated with lower stroke/SEE risk in anticoagulated AF patients

Literature - June 26, 2019 - Boriani G et al., - Eur Heart J. 2019

© 2006 - 2019 pace-cme.org - About